Gusto Global
Mark Spizer is a seasoned executive with extensive experience in both healthcare and real estate sectors. As Co-Founder and Chief Operating Officer of Gusto Global since September 2016, Mark has played a pivotal role in advancing microbiome discovery and therapeutics. Additionally, Mark serves as a Partner at Ruddigore Partners, focusing on early-stage healthcare investments, and as Managing Director at Fennebresque & Co., where strategic consulting and venture capabilities are emphasized. Previous roles include Director of Asset Management at SRSA Commercial Real Estate and Real Estate Portfolio Manager at ING Investment Management. Mark began their career as an Analyst at HFF after earning a Bachelor of Science in Finance and Economics from Florida State University.
This person is not in any teams
This person is not in any offices
Gusto Global
Gusto Global is a biotechnology company that revolutionizes human health by building the discovery and development platform that applies ecological principles to restore key functionalities of a healthy microbiome. The company's platform integrates advanced computational and microbiological tools to discover and develop novel LiveBiotherapeutic Products (LBPs) with unprecedented speed and efficiency. Its ecological approach combines proprietary bioinformatics, AI, and microbiology expertise to identify differences in core microbiome functionalities between healthy and unhealthy individuals. Gusto's live biotherapeutics and companion diagnostics offer the potential for safer and more effective patient-centric care through disease prevention, early detection/diagnosis, intervention, and monitoring.Gusto Global was founded in 2015 and is headquartered in Charlotte, North Carolina.